Security record · archived quarter
VRTX
Vertex Pharmaceuticals Incorporated · Healthcare · Biotechnology
19Tracked holders
-2Δ holders
60.41MShares held
$29.28BReported value
+0New positions
−2Exits
Momentum inputs (comparable managers):
holder breadth -9.5% ·
share flow +0.6% ·
net new positions -10.5%
— formula
Concentrated accumulation — rising shares among fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 175 | -1 | 212.02M | $105.17B | +5 | −5 |
| Q1 2026 | 178 | 0 | 208.95M | $93.29B | +5 | −6 |
| Q4 2025 | 177 | -1 | 219.78M | $99.62B | +2 | −2 |
| Q3 2025 | 26 | +1 | 120.93M | $47.35B | +1 | −1 |
| Q2 2025 | 23 | +1 | 112.15M | $49.92B | +3 | −2 |
| Q1 2025 | 19 | -2 | 60.41M | $29.28B | — | −2 |
| Q4 2024 | 21 | +1 | 60.08M | $24.19B | +1 | — |
| Q3 2024 | 19 | 0 | 46.24M | $21.49B | — | — |
| Q2 2024 | 19 | — | 46.47M | $21.77B | — | — |
Who holds it · Q1 2025
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Capital World Investors ✦ | 28.53M | +0.7% | $13.83B | 2.2% | ▲ Add | 4 | SEC ↗ |
| 2 | State Street Global Advisors ✦ (passive) | 11.79M | -1.6% | $5.72B | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 5.76M | +2.0% | $2.78B | 0.2% | ▲ Add | 4 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 5.76M | +2.0% | $2.78B | 0.2% | ▲ Add | 4 | SEC ↗ |
| 5 | Wellington Management ✦ | 5.45M | -7.8% | $2.64B | 0.5% | ▼ Trim | 4 | SEC ↗ |
| 6 | Wellington Management ✦ | 5.45M | -7.8% | $2.64B | 0.5% | ▼ Trim | 4 | SEC ↗ |
| 7 | Wellington Management ✦ | 5.45M | -7.8% | $2.64B | 0.5% | ▼ Trim | 4 | SEC ↗ |
| 8 | Wellington Management ✦ | 5.45M | -7.8% | $2.64B | 0.5% | ▼ Trim | 4 | SEC ↗ |
| 9 | Wellington Management ✦ | 5.45M | -7.8% | $2.64B | 0.5% | ▼ Trim | 4 | SEC ↗ |
| 10 | Wellington Management ✦ | 5.45M | -7.8% | $2.64B | 0.5% | ▼ Trim | 4 | SEC ↗ |
| 11 | Wellington Management ✦ | 5.45M | -7.8% | $2.64B | 0.5% | ▼ Trim | 4 | SEC ↗ |
| 12 | Wellington Management ✦ | 5.45M | -7.8% | $2.64B | 0.5% | ▼ Trim | 4 | SEC ↗ |
| 13 | Norges Bank ✦ (passive) | 3.36M | -1.5% | $1.63B | 0.2% | ▼ Trim | 4 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 2.92M | +72.5% | $1.41B | 0.2% | ▲ Add | 4 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 2.92M | +72.5% | $1.41B | 0.2% | ▲ Add | 4 | SEC ↗ |
| 16 | Renaissance Technologies ✦ | 1.17M | -16.1% | $568.00M | 0.9% | ▼ Trim | 4 | SEC ↗ |
| 17 | Adage Capital Partners ✦ | 489.67K | +134.0% | $237.40M | 0.4% | ▲ Add | 4 | SEC ↗ |
| 18 | Millennium Management ✦ | 309.94K | -0.2% | $150.26M | 0.2% | ▼ Trim | 4 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 145.87K | -40.6% | $69.63M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 145.87K | -40.6% | $69.63M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 145.87K | -40.6% | $69.63M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 145.87K | -40.6% | $69.63M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 145.87K | -40.6% | $69.63M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 24 | Marshall Wace ✦ | 138.00K | -28.9% | $66.91M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 25 | Marshall Wace ✦ | 138.00K | -28.9% | $66.91M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 26 | Baillie Gifford ✦ | 134.47K | -10.3% | $65.19M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 27 | Baillie Gifford ✦ | 134.47K | -10.3% | $65.19M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 28 | Baillie Gifford ✦ | 134.47K | -10.3% | $65.19M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 29 | Baillie Gifford ✦ | 134.47K | -10.3% | $65.19M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 30 | D. E. Shaw & Co. ✦ | 71.93K | -72.9% | $34.87M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 31 | D. E. Shaw & Co. ✦ | 71.93K | -72.9% | $34.87M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 32 | Tweedy, Browne ✦ | 38.32K | -5.7% | $18.58M | 1.6% | ▼ Trim | 4 | SEC ↗ |
| 33 | Fisher Asset Management ✦ | 30.67K | +2.5% | $14.87M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 34 | Gotham Asset Management ✦ | 27.78K | -7.8% | $13.47M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 35 | ARK Investment Management ✦ | 26.34K | +3.9% | $12.77M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 36 | Citadel Advisors ✦ | 5.02K | -96.9% | $2.43M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 37 | Two Sigma Investments ✦ | 4.12K | -87.6% | $2.00M | 0.0% | ▼ Trim | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Arrowstreet Capital | $3.73M | was 0.0% |
| Bridgewater Associates | $285,917 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1,678 holders, 225.07M shares, $98.10B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q1 2025 ·
Methodology ·
Get this via the API